Search Results

You are looking at 1 - 5 of 5 items for

  • Author: A P West x
  • Refine by access: All content x
Clear All Modify Search
A P West
Search for other papers by A P West in
Google Scholar
PubMed
Close
,
C McKinnell
Search for other papers by C McKinnell in
Google Scholar
PubMed
Close
,
R M Sharpe
Search for other papers by R M Sharpe in
Google Scholar
PubMed
Close
, and
P T K Saunders
Search for other papers by P T K Saunders in
Google Scholar
PubMed
Close

Abstract

The aim of this study was to explore whether pituitary adenylate cyclase activating polypeptide (PACAP) could regulate protein synthesis by enriched preparations of spermatocytes and spermatids from the adult rat testis. Spermatocytes and spermatids were incubated for 8 h or 24 h in the absence (control) or presence of PACAP-27, PACAP-38, vasoactive intestinal peptide (VIP) or dibutyryl adenosine-3′,5′-cyclic monophosphate (db-cAMP). Total synthesis of intracellular and secreted proteins, during the incubation periods, was assessed and selected samples were analysed by 2-D SDS-PAGE. PACAP-38 (200 nm), VIP (200 nm) and db-cAMP (1 mm) significantly increased the synthesis of spermatocyte-secreted and intracellular proteins by 8 h and 24 h. Synthesis of both intracellular and secreted proteins by spermatids was significantly inhibited at 8 h and 24 h with PACAP, VIP and db-cAMP. The abundance of four germ cell-secreted proteins (GSP1, GSP2, GSP3 and phosphatidyethanolamine-binding protein (PEBP)), which can be identified in both spermatocyte and spermatid culture medium, and β-actin, which can only be identified in spermatid culture medium, was analysed. PACAP-38 and db-cAMP significantly increased the incorporation of label into GSP1, GSP2, GSP3 and PEBP, derived from spermatocyte culture medium, at 8 h and 24 h. In contrast PACAP-38 inhibited the incorporation of label into GSP1 and β-actin, derived from spermatid culture medium, at 24 h. The results show that PACAP can regulate synthesis of both secreted and intracellular proteins by spermatids and spermatocytes in vitro. This effect is mimicked with high doses of db-cAMP (>1 mm), suggesting that PACAP may act via a pathway that involves changes in cyclic AMP concentration in the germ cells.

Journal of Endocrinology (1995) 144, 215–223

Restricted access
J. R. BLAIR-WEST
Search for other papers by J. R. BLAIR-WEST in
Google Scholar
PubMed
Close
,
J. P. COGHLAN
Search for other papers by J. P. COGHLAN in
Google Scholar
PubMed
Close
,
D. A. DENTON
Search for other papers by D. A. DENTON in
Google Scholar
PubMed
Close
,
ANGELA P. GIBSON
Search for other papers by ANGELA P. GIBSON in
Google Scholar
PubMed
Close
,
CATHERINE J. ODDIE
Search for other papers by CATHERINE J. ODDIE in
Google Scholar
PubMed
Close
,
W. H. SAWYER
Search for other papers by W. H. SAWYER in
Google Scholar
PubMed
Close
, and
B. A. SCOGGINS
Search for other papers by B. A. SCOGGINS in
Google Scholar
PubMed
Close

Plasma renin activity (PRA) and blood aldosterone and deoxycorticosterone levels were measured in Australian lungfish. Plasma renin activity was depressed after intravenous infusions of iso-osmotic (0·6%) NaCl but not after hypo-osmotic (0·3%) infusions. The presence of PRA in this fish is consistent with prior reports of renal renin activity in other sarcopterygian fishes. The results of the infusion experiments suggest that a fall in plasma osmolality or electrolyte concentrations may oppose the reduction in renin release in response to volume expansion.

Aldosterone and deoxycorticosterone were identified in the blood of Neoceratodus. The concentrations of both appeared higher in females than in males. Infusions of [5-valine]-angiotensin II amide for 2–4 h at rates known to increase blood pressure in this species did not alter blood aldosterone concentrations. This negative finding may suggest that the renin/angiotensin system is not involved in aldosterone regulation in Neoceratodus or that angiotensin receptors involved in regulation of steroidogenesis have a greater specificity for endogenous angiotensin than do vascular receptors.

Restricted access
M. A. Lumsden
Search for other papers by M. A. Lumsden in
Google Scholar
PubMed
Close
,
C. P. West
Search for other papers by C. P. West in
Google Scholar
PubMed
Close
,
R. A. Hawkins
Search for other papers by R. A. Hawkins in
Google Scholar
PubMed
Close
,
T. A. Bramley
Search for other papers by T. A. Bramley in
Google Scholar
PubMed
Close
,
L. Rumgay
Search for other papers by L. Rumgay in
Google Scholar
PubMed
Close
, and
D. T. Baird
Search for other papers by D. T. Baird in
Google Scholar
PubMed
Close

ABSTRACT

Since uterine leiomyomata (fibroids) are not found in conditions where oestradiol is either absent or present only in low concentrations, oestradiol is considered to be an important factor in the control of fibroid growth. To investigate whether this is due to a direct effect on the tissue, oestradiol and progestogen receptors were measured in tissue removed at hysterectomy from 12 normally cycling women and 13 women who had received the gonadotrophin-releasing hormone (GnRH) agonist Zoladex (ICI 118630) as a subcutaneous depot given at monthly intervals for 3 months preoperatively and a third group of three women who had received the antioestrogen tamoxifen (20 mg daily) for 3 months before surgery. Both unoccupied oestradiol receptors (measured by separating bound from free hormone with dextran-coated charcoal; DCC) and 'total' receptor populations (as measured by an enzyme immunoassay) were measured in each fibroid and adjoining myometrium. There was significantly more binding of both oestradiol and progestogen to fibroid than to myometrium in both the control (P <0·01) and agonist-treated groups (P <0·05). Oestradiol binding to fibroids in women treated with Zoladex exceeded that in the normally cycling women (P <0·05) which in turn exceeded that in the tamoxifen-treated group (P <0·05). However, the binding of progestogen, measured by DCC showed the reverse trend. These results may be explained by the low circulating oestradiol concentration in the GnRH agonist-treated women leading to low receptor occupancy.

Journal of Endocrinology (1989) 121, 389–396

Restricted access
J. R. BLAIR-WEST
Search for other papers by J. R. BLAIR-WEST in
Google Scholar
PubMed
Close
,
J. P. COGHLAN
Search for other papers by J. P. COGHLAN in
Google Scholar
PubMed
Close
,
D. A. DENTON
Search for other papers by D. A. DENTON in
Google Scholar
PubMed
Close
,
D. T. W. FEI
Search for other papers by D. T. W. FEI in
Google Scholar
PubMed
Close
,
K. J. HARDY
Search for other papers by K. J. HARDY in
Google Scholar
PubMed
Close
,
B. A. SCOGGINS
Search for other papers by B. A. SCOGGINS in
Google Scholar
PubMed
Close
, and
R. D. WRIGHT
Search for other papers by R. D. WRIGHT in
Google Scholar
PubMed
Close

Comparisons of aldosterone responses to [des-Asp1]-angiotensin II and angiotensin II, often at single dose levels, have shown a wide range of potency ratios. Therefore four-point dose–response comparisons were performed in sodium-replete sheep, using i.v. infusion rates of angiotension II and angiotensin II amide that reproduced the physiological range of blood concentration of angiotensin II for sheep. Angiotensin III was infused i.v. at the same rates. Effects on arterial blood pressure, cortisol secretion rate, adrenal blood flow and plasma levels of Na+ and K+ were also compared. The potency ratio, angiotensin III: angiotensin II amide, was 0·87 for actual aldosterone secretion rate and 0·90 for the calculated increase in aldosterone secretion. For angiotensin III: angiotensin II the ratios were 0·80 and 0·91 respectively. These ratios were not significantly different from 1·00 but the tendency for angiotensin II to be slightly more potent was probably due to a contribution from derived angiotensin III during infusion of angiotensin II. Angiotensin II or angiotensin II amide was ∼ four times as potent as angiotensin III in raising arterial blood pressure. Cortisol secretion rate was slightly but significantly increased by all peptides at the higher infusion rates. Infusions had no effect on adrenal blood flow or plasma levels of Na + but raised plasma levels of K + slightly. These results confirm the conclusion from adrenal arterial infusion experiments that angiotensin II and III are almost equipotent in stimulating aldosterone secretion in sheep.

Restricted access
J. R. BLAIR-WEST
Search for other papers by J. R. BLAIR-WEST in
Google Scholar
PubMed
Close
,
A. BRODIE
Search for other papers by A. BRODIE in
Google Scholar
PubMed
Close
,
J. P. COGHLAN
Search for other papers by J. P. COGHLAN in
Google Scholar
PubMed
Close
,
D. A. DENTON
Search for other papers by D. A. DENTON in
Google Scholar
PubMed
Close
,
C. FLOOD
Search for other papers by C. FLOOD in
Google Scholar
PubMed
Close
,
J. R. GODING
Search for other papers by J. R. GODING in
Google Scholar
PubMed
Close
,
B. A. SCOGGINS
Search for other papers by B. A. SCOGGINS in
Google Scholar
PubMed
Close
,
J. F. TAIT
Search for other papers by J. F. TAIT in
Google Scholar
PubMed
Close
,
S. A. S. TAIT
Search for other papers by S. A. S. TAIT in
Google Scholar
PubMed
Close
,
E M. WINTOUR
Search for other papers by E M. WINTOUR in
Google Scholar
PubMed
Close
, and
R. D. WRIGHT
Search for other papers by R. D. WRIGHT in
Google Scholar
PubMed
Close

SUMMARY

The effect of sodium depletion on the conversion of corticosterone to aldosterone has been examined in vivo using the adrenal transplants of two sheep. [3H]Corticosterone was infused continuously directly into the adrenal gland via the carotid artery over a period of 30 min. and the total adrenal effluent was collected via the jugular vein in six consecutive 5-min. samples. The conversion of [3H]corticosterone to [3H]aldosterone and the endogenous output of aldosterone was measured in each sample using a double isotope derivative method and the specific activity of the aldosterone calculated. Radioactive conversion of B → aldosterone reached equilibrium within 10 min. of the start of infusion and remained constant over a period of 10–25 min. Aldosterone secretion was also constant during the first 25 min. of infusion.

In the same sheep the mean percentage conversion increased as aldosterone secretion rose over a range of 2–12 μg./hr. With more severe sodium depletion, i.e. with aldosterone secretion rates of 12–16 μg./hr., conversion decreased to that found in the sodium replete state. The specific activity of the aldosterone was constant throughout the mildly deplete range (2–12 μg./hr.) but fell with severe sodium depletion. In the sodium replete range (0–2 μg./hr.) before the introduction of a parotid fistula, the specific activity was the same as in the mildly deplete state. After the introduction of a parotid fistula the specific activity increased as the secretion decreased from 2 to 0 μg.

The validity of the approach and interpretation of the results in terms of the biosynthetic pathways involved are discussed.

Restricted access